Access Pharmaceuticals reverse splits stock one-for-five

By Jennifer Chiou

New York, June 5 - Access Pharmaceuticals, Inc. announced a one-for-five reverse stock split.

The company said that the split took effect on Monday and that its stock, under "ACCP," will be traded on the OTC Bulletin Board.

Shareholders approved the split at a May 19 meeting and the company added that it will have 3.5 million outstanding shares.

Dallas-based Access is an emerging pharmaceutical company developing polymer linked cytotoxics for use in the treatment of cancer.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.